Kaplowitz P.B., Oberfield S.E. (1999) Reexamination of the age limit for defining when puberty is precocious in girls in the United States: Implications for evaluation and treatment. Pediatrics 104:936-941.
Herman-Giddens M.E., Slora E.J., Wasserman R.C. (1997) Secondary sexual characteristics and menses in young girls seen in office practice: A study from the Pediatrics Research in Office Settings Network. Pediatrics 99:505-512.
Tanner J.M., Davies P.S.W. (1985) Clinical longitudinal standards for height and height velocity for North American children. Pediatrics 107:317-329.
MacMahon B. Age at menarche: United States-1973, Rockville, MD: National Center for Health Statistics. [DHEW publication no (HRA)74-1615]; 1974.
Hergenroeder A.C., Hill R.B., Wong W.W. (1999) Validity of self-assessment of pubertal maturation in African American and European American adolescents. J Adol Health 24:201-205.
Krstevska-Konstantinova M., Charlier C., Craen M. Sexual precocity after immigration from developing countries to Belgium: Evidence of previous exposure to organochlorine pesticides, submitted; 2000.
Jung H., Carmel P., Schwartz M.S. (1999) Some hypothalamic hamartomas contain transforming growth factor α, a puberty-inducing growth factor, but not Luteinizing Hormone-Releasing Hormone neurons. J Clin Endocrinol Metab 84:4695-4701.
Lebrethon M.C., Vandersmissen E., Gérard A. (2000) Cocaine and amphetamine-regulated-transcript peptide mediation of leptin stimulatory effect on the rat Gonadotropin Releasing Hormone pulse generator in vitro. J Neuroendocrinol 12(12):383-385.
Quinton N.D., Smith R.F., Clayton P.E. (1999) Leptin binding activity changes with age: The link between leptin and puberty. J Clin Endocrinol Metab 84:2336-2341.
Palmert M.R., Radovick S., Boepple P.A. (1998) The impact of reversible gonadal sex steroid suppression on serum leptin concentrations in children with central precocious puberty. J Clin Endocrinol Metab 83:1091-1096.
Heger S., Partsch C.J., Peter M. (1999) Serum leptin levels in patients with progressive central precocious puberty. Pediatr Res 46:71-75.
Farooqi I.S., Jebb S.A., Langmack G. (1999) Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 341:879-884.
Proos L.A., Hofvander Y., Tuvemo T. (1991) Menarcheal age and growth pattern of Indian girls adopted in Sweden. Acta Paediatr Scand 80:852-858.
Shenker A., Laue L., Kosugi S. (1993) A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 365:652-654.
Kremer H., Mariman E., Otten B.J. (1993) Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty. Hum Mol Gen 2:1779-1783.
Laue L., Chan W.-Y., Hsueh A.J.W. (1995) Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. Proc Natl Acad Sci USA 92:1906-1910.
Kremer H., Martens J.W.M., Van Reen M. (1999) A limited repertoire of mutations of the luteinizing hormone receptor gene in familial and sporadic patients with male LH-independent precocious puberty. J Clin Endocrinol Metab 84:1136-1140.
Liu G., Duranteau L., Carel J.C. (1999) Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N Engl J Med 341:1731-1736.
Weinstein L.S., Shenker A., Gejman P.V. (1991) Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Eng J Med 325:1688-1695.
Lumbroso S., Caubel C., Raingeard I. (1998) Activating Gsα mutations: Analysis of 43 DNAs from patients presenting signs of McCune-Albright syndrome - A collaborative study. Horm Res 50(SUPPL. 3):20.
Pienkowski C., Lumbroso S., Bieth E. (1997) Recurrent ovarian cyst and mutation of the Gsα gene in ovarian cyst fluid cells: What is the link with McCune-Albright syndrome?. Acta Paediatr 86:1019-1021.
Rodriguez-Macias K.A., Thibaud E., Houang M. (1999) Follow-up of precocious pseudopuberty associated with isolated ovarian follicular cysts. Arch Dis Child 81:53-56.
Batista M.C., Kohek M.B.F., Frazzatto E.S.T. (2000) Mutation analysis of the follicle-stimulating hormone receptor gene in girls with gonadotropin-independent precocious puberty resulting from autonomous cystic ovaries. Fertility and Sterility 73:280-283.
Villares Fragoso M.C.B., Latronico A.C., Carvalho F.M. (1998) Activating mutation of the stimulatory G protein as a putative cause of ovarian and testicular human stromal Leydic cell tumors. J Clin Endocrinol Metab 83:2074-2078.
Haber H.P., Wollmann H.A., Ranke M.B. (1995) Pelvic ultrasonography: Early differentiation between isolated premature thelarche and central precocious puberty. Eur J Pediatr 154:182-186.
Griffin U., Cole T.J., Duncan K.A. (1995) Pelvic ultrasound findings in different forms of sexual precocity. Acta Paediatr 84:544-549.
Buzi F., Pilotta A., Dordoni D. (1998) Pelvic ultrasonography in normal girls and in girls with pubertal precocity. Acta Paediatr 87:1138-1145.
Oerter Klein K., Mericq V., Brown-Dawson J.M. (1999) Estrogen levels in girls with premature thelarche compared with normal prepubertal girls as determined by an ultrasensitive recombinant cell bioassay. J Pediatr 134:190-192.
Oerter Klein K., Baron J., Barnes K.M. (1998) Use of an ultrasensitive recombinant cell bioassay to determine estrogen levels in girls with precocious puberty treated with a Luteinizing Hormone-Releasing Hormone agonist. J Clin Endocrinol Metab 83:2387-2389.
Oerter K.E., Uriarte M.M., Rose S.R. (1990) Gonadotropin secretory dynamics during puberty in normal girls and boys. J Clin Endocrinol Metab 71:1251-1258.
Brito V.N., Batista M.C., Borges M.F. (1999) Diagnostic value of fluorometric assays in the evaluation of precocious puberty. J Clin Endocrinol Metab 84:3539-3544.
Pescovitz O.H., Hench K.D., Barnes K.M. (1988) Premature thelarche and central precocious puberty: The relation between clinical presentation and the gonadotropin response to Luteinizing Hormone-Releasing Hormone. J Clin Endocrinol Metab 67:474-479.
Fontoura M., Brauner R., Prevot C. (1989) Precocious puberty in girls: Early diagnosis of a slowly progressing variant. Arch Dis Child 64:1170-1176.
Palmert M.R., Malin H.V., Boepple P.A. (1999) Unsustained or slowly progressive puberty in young girls: Initial presentation and long-term follow-up of 20 untreated patients. J Clin Endocrinol Metab 84:415-423.
Pasquino A.M., Pucarelli I., Passeri F. (1995) Progression of premature thelarche to central precocious puberty. J Pediatr 126:11-14.
Volta C., Bernasconi S., Cisternino M. (1998) Isolated premature thelarche and thelarche variant: Clinical and auxological follow-up of 119 girls. J Endocrinol Invest 21:180-183.
Lawson M.L., Cohen N. (1999) A single sample subcutaneous Luteinizing Hormone-releasing Hormone stimulation test for monitoring LH suppression in children with central precocious puberty receiving LHRH agonists. J Clin Endocrinol Metab 84:4536-4540.
Salerno M., Di Maio S., Gasparini N. (1998) Central precocious puberty: A single blood sample after Gonadotropin-releasing hormone agonist administration in monitoring treatment. Horm Res 50:205-211.
Mul D., De Muinck Keizer-Schrama S.M.P.F., Oostdijk W. (1999) Auxological and biochemical evaluation of pubertal suppression with the GnRH agonist leuprolide acetate in early and precocious puberty. Horm Res 51:270-276.
Oerter Klein K. (1999) Editorial: Precocious puberty: Who has it? Who should be treated?. J Clin Endocrinol Metab 84:411-414.
Kreiter M., Burstein S., Rosenfield R.L. (1990) Preserving adult height potential in girls with idiopathic true precocious puberty. J Pediatr 117:364-370.
Heger S., Partsch C.J., Sippell W.G. (1999) Long-term outcome after depot Gonadotropin-releasing hormone agonist treatment of central precocious puberty: Final height, body proportions, body composition, bone mineral density and reproductive function. J Clin Endocrinol Metab 84:4583-4590.
Carel J.C., Roger M., Ispas S. (1999) Final height after long-term treatment with triptorelin slow release for central precocious puberty: Importance of statural growth after interruption of treatment. J Clin Endocrinol Metab 84:1973-1978.
Cassio A., Cacciari E., Balsamo A. (1999) Randomised trial of LHRH analogue treatment on final height in girls with onset of puberty aged 7.5-8.5 years. Arch Dis Child 81:329-332.
Bouvattier C., Coste J., Rodrigue D. (1999) Lack of effect of GnRH agonists on final height in girls with advanced puberty: A randomized long-term pilot study. J Clin Endocrinol Metab 84:3575-3578.
Walvoord E.C., Pescovitz O.H. (1999) Combined use of growth hormone and Gonadotropin-releasing hormone analogues in precocious puberty: Theoretic and practical considerations. Pediatrics 104:1010-1014.
Bertelloni S., Baroncelli G.I., Sorrentino M.C. (1998) Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females. Eur J Pediatr 157:363-367.
Boot A.M., De Muinck Keizer-Schrama S.M.P.F., Pols H.A.P. (1998) Bone mineral density and body composition before and during treatment with Gonadotropin-Releasing Hormone agonist in children with central precocious and early puberty. J Clin Endocrinol Metab 83:370-373.
Antoniazzi F., Bertoldo F., Lauriola S. (1999) Prevention of bone demineralization by calcium supplementation in precocious puberty during Gonadotropin-releasing hormone agonist treatment. J Clin Endocrinol Metab 84:1992-1996.
Feuillan P.P., Jones J.V., Barnes K. (1999) Reproductive axis after discontinuation of Gonadotropin-releasing hormone analog treatment of girls with precocious puberty: Long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty. J Clin Endocrinol Metab 84:44-49.
Xhrouet-Heinrichs D., Lagrou K., Heinrichs C. (1997) Longitudinal study of behavioral and affective patterns in girls with central precocious puberty during long-acting triptorelin therapy. Acta Paediatr 86:808-815.
Werber Leschek E., Jones J., Barnes K.M. (1999) Six-year results of spironolactone and testolactone treatment of familial male-limited precocious puberty with addition of deslorelin after central puberty onset. J Clin Endocrinol Metab 84:175-178.
Holland F.J., Fishman L., Batley J.D. (1985) Ketoconazole in the management of precocious puberty not responsive to LHRH-analogue therapy. N Engl J Med 312:1023-1028.
Feuillan P.P., Jones J., Cutler G.B. (1993) Long term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome. J Clin Endocrinol Metab 77:647-651.
Eugster E.A., Shankar R., Feezle L.K. (1999) Tamoxifen treatment of progressive precocious puberty in a patient with McCune-Albright syndrome. J Pediatr Endocrinol & Metab 12:681-686.
